Literature DB >> 7424328

The influence of allyl isopropyl acetamide on d-aminolevulinic acid synthetase and cytochrome P-450.

W Klinger, D Müller.   

Abstract

Allyl isopropyl acetamide (AIA) is believed to destroy P-450 and to enhance the d-aminolevulinic acid synthetase (ALAS) activity by lowering the heme pool of the liver parenchymal cell, in this way weakening the negative feed back mechanism, which regulates ALAS synthesis at the translational level. Dose and time dependence of the AIA influence on cytochrome P-450 concentration and P-450 activity argues against this theory, supporting the hypothesis that AIA destroys P-450 only after administration of higher doses (> 300 mg/kg i. p.), but does not influence or even enhances P-450 concentration when given in lower doses which exert an increase in ALAS activity. 25--100 mg/kg AIA i. p. have no significant effect on ALAS activity, 200 mg/kg and higher doses up to 400 mg/kg cause dose-dependent increases in ALAS activity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7424328

Source DB:  PubMed          Journal:  Acta Biol Med Ger        ISSN: 0001-5318


  4 in total

1.  Evidence against involvement of cytochrome P-450 haem in the regulation of synthesis of mammalian liver 5-aminolaevulinate synthase.

Authors:  A A Badawy
Journal:  Biochem J       Date:  1982-03-15       Impact factor: 3.857

2.  Sn-protoporphyrin suppresses chemically induced experimental hepatic porphyria. Potential clinical implications.

Authors:  R A Galbraith; G S Drummond; A Kappas
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

3.  Differential responses to inducers of delta-aminolaevulinate synthase and haem oxygenase during pregnancy.

Authors:  M K Sardana; S Sassa; A Kappas
Journal:  Biochem J       Date:  1981-08-15       Impact factor: 3.857

4.  Assessment of porphyrogenicity of drugs and chemicals in selected hepatic cell culture models through a fluorescence-based screening assay.

Authors:  Christopher D Ma; Cynthia G Van Horn; Meimei Wan; Colin Bishop; Herbert L Bonkovsky
Journal:  Pharmacol Res Perspect       Date:  2022-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.